(Q38115933)

29 August 2017

3 references

22 June 2020

27 May 2022

25 October 2022

Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries (English)

1 reference

29 August 2017

1 reference

1 July 2020

1 reference

1 July 2020

1 reference

1 July 2020

1 reference

1 July 2020

Haemophilus infections

1 reference

22 June 2020

1 reference

1 reference

1 July 2020

Kutub Mahmood

1

1 reference

29 August 2017

Sonia Pelkowski

2

1 reference

29 August 2017

Deborah Atherly

3

1 reference

29 August 2017

Robert D Sitrin

4

1 reference

29 August 2017

John J Donnelly

5

1 reference

29 August 2017

20 June 2013

1 reference

Human Vaccines & Immunotherapeutics

29 August 2017

1 September 2013

10 references

23 March 2019

21 March 2019

25 April 2019

20 June 2019

4 August 2019

22 June 2020

23 June 2020

1 July 2020

27 May 2022

25 October 2022

11 references

29 August 2017

23 March 2019

21 March 2019

25 April 2019

20 June 2019

4 August 2019

22 June 2020

23 June 2020

1 July 2020

27 May 2022

25 October 2022

9

1 reference

29 August 2017

9

1 reference

29 August 2017

1894-1902

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

29 August 2017

10 references

23 March 2019

21 March 2019

25 April 2019

20 June 2019

4 August 2019

22 June 2020

23 June 2020

1 July 2020

27 May 2022

on focus list of Wikimedia project

25 October 2022

ScienceSource

0 references

cites work

A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administ

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906353

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906353

Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906353

Outbreaks of paralytic poliomyelitis, 1976-1995.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906353

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906353

Improving the cellular pertussis vaccine: increased potency and consistency.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906353

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.25407

Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine

21 January 2018

1 reference

12 December 2020

Meeting of the Strategic Advisory Group of Experts on immunization, April 2012--conclusions and recommendations

1 reference

12 December 2020

Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide

1 reference

12 December 2020

Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba

1 reference

12 December 2020

Fractional doses of inactivated poliovirus vaccine in Oman

1 reference

12 December 2020

Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Th

1 reference

12 December 2020

Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants

1 reference

12 December 2020

Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 – conclusions and recommendations

1 reference

12 December 2020

Priming after a Fractional Dose of Inactivated Poliovirus Vaccine

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.25407

1 reference

29 August 2017

1 reference

29 August 2017

1 reference